Is 3D printing of pharmaceuticals a disruptor or enabler?

Journal article

K Liang, D Bambilla, J -C Leroux
Advanced Materials, 2019

DOI: 10.1002/adma.201805680

https://doi.org/10.1002/adma.201805680

Cite

APA Click to copy
Liang, K., Bambilla, D., & Leroux, J.-C. (2019). Is 3D printing of pharmaceuticals a disruptor or enabler? . Advanced Materials. https://doi.org/10.1002/adma.201805680

Chicago/Turabian Click to copy
Liang, K, D Bambilla, and J -C Leroux. “Is 3D Printing of Pharmaceuticals a Disruptor or Enabler? .” Advanced Materials (2019).

MLA Click to copy
Liang, K., et al. “Is 3D Printing of Pharmaceuticals a Disruptor or Enabler? .” Advanced Materials, 2019, doi:10.1002/adma.201805680.

BibTeX Click to copy

@article{k2019a,
  title = {Is 3D printing of pharmaceuticals a disruptor or enabler? },
  year = {2019},
  journal = {Advanced Materials},
  doi = {10.1002/adma.201805680},
  author = {Liang, K and Bambilla, D and Leroux, J -C}
}